REZFYTRIO Trademark

Prosecution Summary

Trademark Summary
REZFYTRIO is a standard character word mark covering pharmaceuticals in International Class 005 for treating and preventing various diseases and disorders including bone, cardiovascular, central nervous system, autoimmune, cancer, diabetes, and others, plus antibiotics, antivirals, anti-inflammatories, and human vaccines; it also spans U.S. classes 006, 018, 044, 046, 051, and 052. The mark is owned by Merck Sharp & Dohme B.V., a Netherlands-based BESLOTEN VENNOOTSCHAP (B.V.). It is registered on the Principal Register as of February 10, 2026 (Registration No. 8137193), with no notable issues or active legal proceedings.

Recent Activity
Filed July 15, 2025, based on foreign priority from a Benelux registration (No. 1528962, filed July 14, 2025). F

Trademark Facts

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

Related

• All trademarks from Merck Sharp & Dohme B.V.
• More marks in Class 005
• Search for similar marks to REZFYTRIO
• Run a clearance check
• Free USPTO trademark search